- Report
- July 2024
- 288 Pages
Global
From €5187EUR$6,130USD£4,350GBP
- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
Complera is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of three drugs: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. Complera is used to treat HIV-1 infection in adults and adolescents aged 12 years and older who have not taken antiretroviral medications before. It is also used to replace a current antiretroviral regimen in adults and adolescents aged 12 years and older who are virologically suppressed on a stable antiretroviral regimen for at least six months.
Complera is a part of the larger HIV/AIDS drug market, which includes a variety of antiretroviral medications used to treat HIV/AIDS. These medications are used to reduce the amount of HIV in the body, prevent the virus from replicating, and reduce the risk of HIV-related illnesses.
Some companies in the Complera market include Gilead Sciences, Janssen Pharmaceuticals, and ViiV Healthcare. Show Less Read more